Evidence map›Paper›PMID 25489952›Full record

ArticleClinical nuclear medicine2015

Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.

Andrei Iagaru, Erik Mittra, Ryogo Minamimoto, Mehran Jamali, Craig Levin, Andrew Quon, Garry Gold, Robert Herfkens, Shreyas Vasanawala, Sanjiv Sam Gambhir and 1 more

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Clinical nuclear medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Correlation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  9. True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation.European journal of nuclear medicine and molecular imaging · 2021
    Article
  10. Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning.European journal of nuclear medicine and molecular imaging · 2020
    Article
  11. Human biodistribution and radiation dosimetry of [European journal of nuclear medicine and molecular imaging · 2020
    Article
  12. Microstrip Transmission Line RF Coil for a PET/MRI Insert.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2020
    Article
  13. Frontiers in medicine · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Ultra-Low-DoseRadiology · 2019
    Article
  18. [Molecular imaging and biology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrei IagaruFrom the *Division of Nuclear Medicine and Molecular Imaging, Stanford University Medical Center; †Stanford University Medical Center, Molecular Imaging Program at Stanford (MIPS); ‡Stanford University Medical Center, Department of Radiology; §Stanford University Medical Center, Departments of Radiology, Bioengineering, Materials Science and Engineering, Molecular Imaging Program at Stanford (MIPS), Stanford, CA.
Erik Mittra
Ryogo Minamimoto
Mehran Jamali
Craig Levin
Andrew Quon
Garry Gold
Robert Herfkens
Shreyas Vasanawala
Sanjiv Sam Gambhir
Greg Zaharchuk

Funding

Advanced MR Imaging of Early OsteoarthritisK24AR062068 · NIAMS · STANFORD UNIVERSITY · PI GOLD, GARRY E · 2012 to 2022
$1.7M
NIAMS NIH HHS K24 AR062068
6 · The paper itself

Abstract

purposeThe recent introduction of hybrid PET/MRI scanners in clinical practice has shown promising initial results for several clinical scenarios. However, the first generation of combined PET/MRI lacks time-of-flight (TOF) technology. Here we report the results of the first patients to be scanned on a completely novel fully integrated PET/MRI scanner with TOF. MATERIALS AND

methodsWe analyzed data from patients who underwent a clinically indicated F FDG PET/CT, followed by PET/MRI. Maximum standardized uptake values (SUVmax) were measured from F FDG PET/MRI and F FDG PET/CT for lesions, cerebellum, salivary glands, lungs, aortic arch, liver, spleen, skeletal muscle, and fat. Two experienced radiologists independently reviewed the MR data for image quality.

resultsThirty-six patients (19 men, 17 women, mean [±standard deviation] age of 61 ± 14 years [range: 27-86 years]) with a total of 69 discrete lesions met the inclusion criteria. PET/CT images were acquired at a mean (±standard deviation) of 74 ± 14 minutes (range: 49-100 minutes) after injection of 10 ± 1 mCi (range: 8-12 mCi) of F FDG. PET/MRI scans started at 161 ± 29 minutes (range: 117 - 286 minutes) after the F FDG injection. All lesions identified on PET from PET/CT were also seen on PET from PET/MRI. The mean SUVmax values were higher from PET/MRI than PET/CT for all lesions. No degradation of MR image quality was observed.

conclusionThe data obtained so far using this investigational PET/MR system have shown that the TOF PET system is capable of excellent performance during simultaneous PET/MR with routine pulse sequences. MR imaging was not compromised. Comparison of the PET images from PET/CT and PET/MRI show no loss of image quality for the latter. These results support further investigation of this novel fully integrated TOF PET/MRI instrument.

Indexed as

Magnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyTomography, X-Ray ComputedWhole Body ImagingAgedAged, 80 and overFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedPilot ProjectsRadiopharmaceuticalsReproducibility of ResultsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID25489952
PMCPMC6319383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.